1. 1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control
- Author
-
Ko FWS, Chan KP, Ng JKC, Ngai JC, Yip WH, Lo RLP, Chan TO, and Hui DSC
- Subjects
asthma ,feno ,serial measurement ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Fanny Wai San Ko,1 Ka Pang Chan,1 Joyce Ka Ching Ng,1 Jenny CL Ngai,1 Wing Ho Yip,1 Rachel Lai Ping Lo,1 Tat On Chan,2 David Shu Cheong Hui1 1Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People’s Republic of China; 2The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, People’s Republic of ChinaCorrespondence: David Shu Cheong Hui, Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, Tel +852 35053128, Email dschui@cuhk.edu.hkBackground and Objective: Previous studies found that the fractional nitric oxide concentration in exhaled breath (FeNO) levels in healthy Chinese adults was higher than in White adults. More understanding of serial changes of FeNO levels with asthma control in a real-life clinical setting would be important to explore the utility of this biomarker in routine asthma management. This study assessed the FeNO levels of Chinese asthma subjects with different levels of asthma control and the serial changes with respect to the changes in asthma control over 1 year.Methods: A 12-month prospective study (subjects recruited between November 2019 and January 2021) with serial measurement of FeNO levels at baseline, 4, 8 and 12 months. Asthma control was assessed by the Global Initiative for Asthma classification, Asthma Control Test (ACT) and Asthma Control Questionnaire (ACQ).Results: Altogether, 136 subjects (mean age 51.51± 15.09 years, 46[33.8%] male) had successful baseline FeNO measurements. At baseline, the FeNO levels did not show a statistically significant difference for controlled, partly controlled and uncontrolled asthma according to GINA classification, ACT and ACQ. FeNO levels decreased with improving asthma control and stayed at similar levels with unchanged or worsening asthma control for all subjects. For subjects with baseline blood eosinophil levels ≥ 300 cells/μL(n=59), FeNO levels decreased with improving asthma control, stayed similar without change for asthma control and increased with worsening asthma control. Receiver operating characteristic (ROC) analysis with the highest area under curve (AUC) for changes in FeNO levels for improving asthma control was between ≤ − 10 to − 25 ppb at various time points in the 12-month study.Conclusion: Changes in FeNO levels over time were associated with changes in clinical asthma control, particularly in those with higher blood eosinophil count and are likely more useful than a single time point measurement in managing asthma.Keywords: asthma, FeNO, serial measurement
- Published
- 2023